Rolapitant treats lung cancer by targeting deubiquitinase OTUD3.
Du T, Gu Q, Zhang Y, Gan Y, Liang R, Yang W, Lu Y, Xu C, Wu J, Ma R, Cao H, Jiang J, Wang J, Feng J.
Du T, et al. Among authors: gan y.
Cell Commun Signal. 2024 Mar 27;22(1):195. doi: 10.1186/s12964-024-01519-8.
Cell Commun Signal. 2024.
PMID: 38539203
Free PMC article.